Literature DB >> 9454773

The Fanconi anemia group C gene product is located in both the nucleus and cytoplasm of human cells.

M E Hoatlin1, T A Christianson, W W Keeble, A T Hammond, Y Zhi, M C Heinrich, P A Tower, G C Bagby.   

Abstract

The Fanconi anemia (FA) complementation group C (FAC) protein gene encodes a cytoplasmic protein with a predicted Mr of 63,000. The protein's function is unknown, but it has been hypothesized that it either mediates resistance to DNA cross-linking agents or facilitates repair after exposure to such factors. The protein also plays a permissive role in the growth of colony-forming unit-granulocyte/macrophage (CFU-GM), burst-forming unit-erythroid (BFU-E), and CFU-erythroid (CFU-E). Attributing a specific function to this protein requires an understanding of its intracellular location. Recognizing that prior study has established the functional importance of its cytoplasmic location, we tested the hypothesis that FAC protein can also be found in the nucleus. Purified recombinant Escherichia coli-derived FAC antigens were used to create antisera able to specifically identify an Mr = 58,000 protein in lysates from human Epstein-Barr virus (EBV)-transformed cell lines by immunoblot analysis. Subcellular fractionation of the cell lysates followed by immunoblot analysis revealed that the majority of the FAC protein was cytoplasmic, as reported previously; however, approximately 10% of FAC protein was reproducibly detected in nuclear fractions. These results were reproducible by two different fractionation methods, and included markers to control for contamination of nuclear fractions by cytoplasmic proteins. Moreover, confocal image analysis of human 293 cells engineered to express FAC clearly demonstrated that FAC protein is located in both cytoplasmic and nuclear compartments, consistent with data obtained from fractionation of the FA cell lines. Finally, complementation of the FAC defect using retroviral-mediated gene transfer resulted in a substantial increase in nuclear FAC protein. Therefore, while cytoplasmic localization of this protein appears to be functionally important, it may also exert some essential nuclear function.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9454773

Source DB:  PubMed          Journal:  Blood        ISSN: 0006-4971            Impact factor:   22.113


  13 in total

1.  FANCE: the link between Fanconi anaemia complex assembly and activity.

Authors:  Paul Pace; Mark Johnson; Wu Meng Tan; Georgina Mosedale; Chelvin Sng; Maureen Hoatlin; Johan de Winter; Hans Joenje; Fanni Gergely; K J Patel
Journal:  EMBO J       Date:  2002-07-01       Impact factor: 11.598

2.  Cytoplasmic FANCA-FANCC complex interacts and stabilizes the cytoplasm-dislocalized leukemic nucleophosmin protein (NPMc).

Authors:  Wei Du; Jie Li; Jared Sipple; Jianjun Chen; Qishen Pang
Journal:  J Biol Chem       Date:  2010-09-23       Impact factor: 5.157

3.  FANCC interacts with Hsp70 to protect hematopoietic cells from IFN-gamma/TNF-alpha-mediated cytotoxicity.

Authors:  Q Pang; W Keeble; T A Christianson; G R Faulkner; G C Bagby
Journal:  EMBO J       Date:  2001-08-15       Impact factor: 11.598

4.  The Fanconi anemia protein FANCC binds to and facilitates the activation of STAT1 by gamma interferon and hematopoietic growth factors.

Authors:  Q Pang; S Fagerlie; T A Christianson; W Keeble; G Faulkner; J Diaz; R K Rathbun; G C Bagby
Journal:  Mol Cell Biol       Date:  2000-07       Impact factor: 4.272

Review 5.  Current knowledge on the pathophysiology of Fanconi anemia: from genes to phenotypes.

Authors:  T Yamashita; T Nakahata
Journal:  Int J Hematol       Date:  2001-07       Impact factor: 2.490

6.  Fanconi anemia proteins FANCA, FANCC, and FANCG/XRCC9 interact in a functional nuclear complex.

Authors:  I Garcia-Higuera; Y Kuang; D Näf; J Wasik; A D D'Andrea
Journal:  Mol Cell Biol       Date:  1999-07       Impact factor: 4.272

7.  A physical complex of the Fanconi anemia proteins FANCG/XRCC9 and FANCA.

Authors:  Q Waisfisz; J P de Winter; F A Kruyt; J de Groot; L van der Weel; L M Dijkmans; Y Zhi; F Arwert; R J Scheper; H Youssoufian; M E Hoatlin; H Joenje
Journal:  Proc Natl Acad Sci U S A       Date:  1999-08-31       Impact factor: 11.205

Review 8.  Molecular pathogenesis of fanconi anemia.

Authors:  Toshiyasu Taniguchi; Alan D Dandrea
Journal:  Int J Hematol       Date:  2002-02       Impact factor: 2.490

9.  The fanconi anemia pathway requires FAA phosphorylation and FAA/FAC nuclear accumulation.

Authors:  T Yamashita; G M Kupfer; D Naf; A Suliman; H Joenje; S Asano; A D D'Andrea
Journal:  Proc Natl Acad Sci U S A       Date:  1998-10-27       Impact factor: 11.205

10.  Functional activity of the fanconi anemia protein FAA requires FAC binding and nuclear localization.

Authors:  D Näf; G M Kupfer; A Suliman; K Lambert; A D D'Andrea
Journal:  Mol Cell Biol       Date:  1998-10       Impact factor: 4.272

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.